ARCHIVES

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

This article is from The Cancer Letter archive.

Vol. 40 No. 38 | October 10, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

NCI Test Panels Available For Marker Evaluation

March 2, 1984

Swedish Study Finds Long Term Hormonal Therapy May Increase Breast Cancer Risk

August 4, 1989

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations

June 6, 1986